The Kentucky Neuroscience Institute (KNI) is discovering new and advanced ways to bring findings from the researcher's lab bench to the patient's bedside through clinical trials and research grants. By combining the expertise of researchers and physicians, KNI can offer the most advanced treatments.
Patients involved in research trials for neurodegenerative diseases are also monitored and evaluated for a longer period of time in comparison to the typical 60 day study. Factors such as ease of movement, communication and overall satisfaction with life are examined from a longitudinal approach. Such studies include the first North American Phase I clinical trial for Parkinson's disease.
Kentucky Neuroscience Institute Clinical Research Organization
The mission of the University of Kentucky Neuroscience Institute Clinical Research Organization (CRO) is to foster the development and support the conduct of world-class neuroscience clinical trials and clinical translational research. Given the ever-changing climate in the health care environment, the increasingly complex requirements for the conduct of clinical studies and care for human research participants necessitate a careful and well-structured management organization. The KNI-CRO serves this role by providing guidance through its clinical trials and research expertise, economies of scale and institutional support. The KNI-CRO is a clinical trial management organization housed in the College of Medicine at the University of Kentucky Medical Center (UKMC). It is comprised of a diverse staff dedicated to implement and conduct clinical research in a timely manner and with the highest standards of Good Clinical Practice.
Interested in Participating?
For general questions contact:
Phone: (859) 218-5050